Clinical Trial Update: Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control [Phase 4]

View source ↗

Summary

Phase 4 trial assessing oral verapamil for preventing recurrence of paroxysmal supraventricular tachycardia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Supraventricular Tachycardia

Drugs mentioned

• Verapamil (verapamil)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Paroxysmal Supraventricular Tachycardia | Phase 4 | Status: COMPLETED